Skip to main content
Clinical Trials/CTRI/2018/05/013887
CTRI/2018/05/013887
Completed
未知

A Randomized Control Trial for Evaluation of Transfusion Related Immuno-Modulation in Patients with Maningioma - niil

All India Institute of Medical sciences AIIMS New Delhi0 sites130 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Patients undergoing elective intrancranial neurosurgery
Sponsor
All India Institute of Medical sciences AIIMS New Delhi
Enrollment
130
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
November 1, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
All India Institute of Medical sciences AIIMS New Delhi

Eligibility Criteria

Inclusion Criteria

  • a) Patients undergoing elective intracranial meningioma neurosurgery.
  • b)Received transfusion of more than 1 units of PRBCs during surgery

Exclusion Criteria

  • a) Patients \<18yrs or \>70yrs of age.
  • b) Having received blood transfusion in less than 6 months prior to the surgery.
  • c) Patient undergoing emergency neurosurgery.
  • d) Patient with any form of active infection; respiratory, UTI

Outcomes

Primary Outcomes

Not specified

Similar Trials